Alzheimer’s Drug Controversy and Clinical Trials Prediction

This week's 'The Readout LOUD' podcast covers a new Alzheimer's drug controversy and prediction markets for clinical trials and FDA reviews. The discussion highlights the ongoing debates in biotech and pharmaceutical research.